1. Ahmadzia HK, Patel EM, Joshi D, et al. Obstetric surgical site infections: 2 grams compared with 3 grams of cefazolin in morbidly obese women. Obstet Gynecol 2015:126:708-15.

2. Forse R, Karam B, Maclean D, Christou N. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989;106:750-7.

3. Ho VP, Nicolau DP, Dakin GF, et al. Cefazolin dosing for surgical prophylaxis in morbidly obese patients. Surg Infect 2012;13:33-7.

4. Maggio L, Nicolau DP, DaCosta M, et al. Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial. Obstet Gynecol 2015;125:1205-10.

5. Peppard WJ, Eberle DG, Kugler NW, et al. Association between pre-operative cefazolin dose and surgical site infection in obese patients. Surg Infect 2017;18:485-90.

6.Ryan RL, Jackson D, Hopkins G, et al.  Plasma and interstitial fluid pharmacokinetics of prophylactic cefazolin in elective bariatric surgery patients.  Antimicrob Agents Chemother 2022;66:1-10.

Swank ML, Wing DA, Nicolau DP, et al. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women. Am J Obstet Gynecol 2015;213:415.e1-8.

7. van Kralingen S, Taks M, Diepstraten J, et al. Pharmacokinetics and protein binding of cefazolin in morbidly obese patients. Eur J Clin Pharmacol 2011;67:985–92.